Upregulation of circular and linear METTL3 and USP3 in colorectal cancer

被引:7
|
作者
Alkhizzi, Bilal [1 ]
Khan, Mohammad Imran [1 ,2 ]
Al-Ghafari, Ayat [1 ,3 ,4 ]
Choudhry, Hani [1 ,2 ]
机构
[1] King Abdulaziz Univ, Fac Sci, Biochem Dept, 90A Al Marsad St, Jeddah 21589, Saudi Arabia
[2] King Abdulaziz Univ, Ctr Artificial Intelligence Precis Med, Jeddah 21589, Saudi Arabia
[3] Dar Al Hekma Univ, Sci Res Ctr, Jeddah 22246, Saudi Arabia
[4] King Abdulaziz Univ, King Fahd Med Res Ctr, Canc & Mutagenesis Unit, Jeddah 21589, Saudi Arabia
关键词
circular RNA; methyltransferase-like; 3; biomarkers; ubiquitin-specific peptidase 3; colorectal cancer; MESSENGER-RNA EXPRESSION; THERAPEUTIC TARGET; APOPTOSIS; PROLIFERATION; BIOMARKER; PCR;
D O I
10.3892/ol.2021.12936
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several screening methods are currently used to detect colorectal cancer (CRC). However, these are either under-utilized due to their invasive nature or are limited in terms of their diagnostic ability. Numerous reports have investigated messenger and circular RNA as non-invasive biomarkers, but the majority of gene expression studies using RT-qPCR involve critical errors that often lead to irreproducible findings. In the present study, several of these issues were addressed. To the best of our knowledge, this study reports for the first time the upregulation of both the circular and the linear isoform of USP3 and METTL3 in leukocytes from patients with CRC. The linear transcripts of USP3 and METTL3 exhibited 2.3- and 2-fold increases on average in CRC samples (n=42 CRC) compared with the respective healthy controls (n=32), whereas their circular isoforms showed 1.6- and 1.7-fold increases, respectively. Moreover, a strong positive correlation was observed between the circular and linear isoforms of USP3 in the CRC cohort (P<0.0001), but not in the control group (P>0.05). In addition, the linear USP3 assay had excellent sensitivity (79%), specificity (75%), positive predictive value (81%), negative predictive value (73%) and area under the curve (AUC, 0.8534; P-value <0.0001). The circular (AUC, 0.6946; P-value =0.0043) and linear (AUC, 0.7202; P-value =0.0012) METTL3 assays also showed potential; however, this was not the case for the circular USP3 assay (P-value >0.05). Taken together, this stringent RT-qPCR approach provides evidence for the viability of using circular and linear RNA molecules as disease biomarkers and may help shed light on the regulatory pathways of CRC.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Upregulation of METTL3, an N(6) - Adenosine Methyltransferase of PolyA plus RNA in Hepatocellular Carcinoma
    Sachak, Taha
    Barajas, Juan
    Ghoshal, Kalpana
    Knight, Debbie
    Chen, Wei
    Frankel, Wendy L.
    LABORATORY INVESTIGATION, 2018, 98 : 647 - 647
  • [32] Prognostic roles of dysregulated METTL3 protein expression in cancers and potential anticancer value by inhibiting METTL3 function
    Zhao, Rong
    Chen, Jiaping
    Wang, Yangwei
    Xiao, Han
    Mei, Peiyuan
    Lin, Wei
    Diao, Mingxin
    He, Shiwen
    Liao, Yongde
    Meng, Wangyang
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (05) : 924 - 939
  • [33] Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
    Xia, Tian-Liang
    Yan, Shu-Mei
    Yuan, Li
    Zeng, Mu-Sheng
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5729 - 5737
  • [34] USP3 controls BRCA1 "foci"
    Raychaudhuri, Pradip
    CELL CYCLE, 2014, 13 (02) : 183 - 183
  • [35] The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target
    Zhou, Xuming
    Chai, Keqiang
    Zhu, Hezhen
    Luo, Cong
    Zou, Xiaofeng
    Zou, Junrong
    Zhang, Guoxi
    BMC CANCER, 2024, 24 (01)
  • [36] Clinical significance of METTL3 expression levels in gastric cancer patients
    Okugawa, Yoshinaga
    Toiyama, Yuji
    Kitajima, Takahito
    Shimura, Tadanobu
    Yokoe, Takeshi
    Hiro, Junichiro
    Kusunoki, Masato
    CANCER SCIENCE, 2021, 112 : 428 - 428
  • [37] The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer
    Haigh, Daisy B.
    Woodcock, Corinne L.
    Lothion-Roy, Jennifer
    Harris, Anna E.
    Metzler, Veronika M.
    Persson, Jenny L.
    Robinson, Brian D.
    Khani, Francesca
    Alsaleem, Mansour
    Ntekim, Atara
    Madhusudan, Srinivasan
    Davis, Melissa B.
    Laursen, Kristian B.
    Gudas, Lorraine J.
    Rutland, Catrin S.
    Toss, Michael S.
    Archer, Nathan
    Bodi, Zsuzsanna
    Rakha, Emad A.
    Fray, Rupert G.
    Jeyapalan, Jennie N.
    Mongan, Nigel P.
    CANCERS, 2022, 14 (20)
  • [38] Mettl3 deficiency leads to the upregulation of Cav1.2 and increases arrhythmia susceptibility in mice
    Shi, Ling
    Jin, Xuexin
    Li, Zheng
    Gong, Rui
    Guo, Yang
    Ma, Jiudong
    Zhang, Yang
    Cai, Benzhi
    Yang, Baofeng
    Gong, Dongmei
    Pan, Zhenwei
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (02) : 199 - 208
  • [39] The molecular mechanism of METTL3 promoting the malignant progression of lung cancer
    Chao Ma
    Rui-Jie Ma
    Kang Hu
    Qi-Ming Zheng
    Ye-Peng Wang
    Nan Zhang
    Zhi-Gang Sun
    Cancer Cell International, 22
  • [40] The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target
    Xuming Zhou
    Keqiang Chai
    Hezhen Zhu
    Cong Luo
    Xiaofeng Zou
    Junrong Zou
    Guoxi Zhang
    BMC Cancer, 24